1 ACYCLOVIR | 70 of 1080 | 670 prescriptions Less than 1% of all prescriptions | | 220 patients 26% of all patients | < 11 | |
2 IMATINIB MESYLATE | 10 of 80 | 830 prescriptions Less than 1% of all prescriptions | 830 | 110 patients 13% of all patients | 110 patients 13% of all patients | |
3 JAKAFI (RUXOLITINIB PHOSPHATE) | 30 of 70 | 490 prescriptions Less than 1% of all prescriptions | 360 | < 11 | < 11 | |
4 ALLOPURINOL | 720 of 4630 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
5 SPRYCEL (DASATINIB) | 20 of 40 | 390 prescriptions Less than 1% of all prescriptions | 390 | < 11 | < 11 | |
6 IMBRUVICA (IBRUTINIB) | 20 of 50 | 440 prescriptions Less than 1% of all prescriptions | 440 | < 11 | < 11 | |
7 HYDROXYUREA | 90 of 140 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 TASIGNA (NILOTINIB HCL) | 20 of 30 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 BOSULIF (BOSUTINIB) | 20 of 20 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
10 XARELTO (RIVAROXABAN) | 600 of 3290 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
11 NEXAVAR (SORAFENIB TOSYLATE) | 10 of 20 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 ICLUSIG (PONATINIB HCL) | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
13 REVLIMID (LENALIDOMIDE) | 70 of 80 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
14 LEVOFLOXACIN | 370 of 1900 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | A |
15 ONDANSETRON HCL | 240 of 1350 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |